# Lyft, Inc.: financial statements, quarterly

LYFT · Nasdaq · CIK 1759509 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/lyft.md) · [Financials](/companies/lyft/financials.md) · [Filings](/companies/lyft/filings.md) · [Insiders](/companies/lyft/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/lyft/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,070](/filings/0001759509-24-000128.md) | [1,153 d](/filings/0001628280-26-006960.md) | [1,210](/filings/0001759509-25-000088.md) | [1,322](/filings/0001759509-25-000126.md) | [1,388](/filings/0001628280-25-049701.md) | [1,446 d](/filings/0001628280-26-006960.md) | [1,374](/filings/0001759509-25-000088.md) | [1,477](/filings/0001759509-25-000126.md) | [1,546](/filings/0001628280-25-049701.md) | [1,498 d](/filings/0001628280-26-006960.md) | [1,650](/filings/0001628280-26-032412.md) | [1,844](/filings/0001628280-26-054499.md) |
| Cost of revenue | $m | [645](/filings/0001759509-24-000128.md) | [744 d](/filings/0001628280-26-006960.md) | [755](/filings/0001759509-25-000088.md) | [820](/filings/0001759509-25-000126.md) | [888](/filings/0001628280-25-049701.md) | [875 d](/filings/0001628280-26-006960.md) | [863](/filings/0001628280-26-032412.md) | [936](/filings/0001628280-26-054499.md) | [927](/filings/0001628280-25-049701.md) | [972 d](/filings/0001628280-26-006960.md) | [864](/filings/0001628280-26-032412.md) | [926](/filings/0001628280-26-054499.md) |
| Research and development | $m | [109](/filings/0001759509-24-000128.md) | [95.2 d](/filings/0001628280-26-006960.md) | [100](/filings/0001759509-25-000088.md) | [98.8](/filings/0001759509-25-000126.md) | [104](/filings/0001628280-25-049701.md) | [93.8 d](/filings/0001628280-26-006960.md) | [112](/filings/0001628280-26-032412.md) | [109](/filings/0001628280-26-054499.md) | [110](/filings/0001628280-25-049701.md) | [120 d](/filings/0001628280-26-006960.md) | [124](/filings/0001628280-26-032412.md) | [119](/filings/0001628280-26-054499.md) |
| Operating income | $m | [(40.2)](/filings/0001759509-24-000128.md) | [(60.2) d](/filings/0001628280-26-006960.md) | [(63.0)](/filings/0001759509-25-000088.md) | [(27.2)](/filings/0001759509-25-000126.md) | [(56.7)](/filings/0001628280-25-049701.md) | [28.0 d](/filings/0001628280-26-006960.md) | [(28.8)](/filings/0001628280-26-032412.md) | [2.4](/filings/0001628280-26-054499.md) | [23.1](/filings/0001628280-25-049701.md) | [(185) d](/filings/0001628280-26-006960.md) | [(5.3)](/filings/0001628280-26-032412.md) | [47.6](/filings/0001628280-26-054499.md) |
| Interest expense | $m | [6.2](/filings/0001759509-23-000115.md) | [8.4 d](/filings/0001759509-24-000019.md) | [7.0](/filings/0001759509-24-000069.md) | [7.9](/filings/0001759509-25-000126.md) | [7.4](/filings/0001628280-25-049701.md) | [6.7 d](/filings/0001628280-26-006960.md) | [6.2](/filings/0001628280-26-032412.md) | [5.0](/filings/0001628280-26-054499.md) | [4.7](/filings/0001628280-25-049701.md) | [4.8 d](/filings/0001628280-26-006960.md) | [5.2](/filings/0001628280-26-032412.md) | [5.5](/filings/0001628280-26-054499.md) |
| Income tax | $m | [0.1](/filings/0001759509-24-000128.md) | [3.2 d](/filings/0001628280-26-006960.md) | [2.6](/filings/0001759509-25-000088.md) | [1.9](/filings/0001759509-25-000126.md) | [(0.7)](/filings/0001628280-25-049701.md) | [(1.2) d](/filings/0001628280-26-006960.md) | [3.4](/filings/0001628280-26-032412.md) | [4.1](/filings/0001628280-26-054499.md) | [(2.0)](/filings/0001628280-25-049701.md) | [(2,903) d](/filings/0001628280-26-006960.md) | [5.5](/filings/0001628280-26-032412.md) | [28.1](/filings/0001628280-26-054499.md) |
| Net income | $m | [(12.1)](/filings/0001759509-24-000128.md) | [(26.3) d](/filings/0001628280-26-006960.md) | [(31.5)](/filings/0001628280-25-049701.md) | [5.0](/filings/0001628280-25-049701.md) | [(12.4)](/filings/0001628280-25-049701.md) | [61.7 d](/filings/0001628280-26-006960.md) | [2.6](/filings/0001628280-26-054499.md) | [40.3](/filings/0001628280-26-054499.md) | [46.1](/filings/0001628280-25-049701.md) | [2,755 d](/filings/0001628280-26-006960.md) | [14.3](/filings/0001628280-26-054499.md) | [50.3](/filings/0001628280-26-054499.md) |
| Diluted EPS | $ per share | [(0.03)](/filings/0001759509-24-000128.md) | not reported | [(0.08)](/filings/0001759509-25-000088.md) | [0.01](/filings/0001759509-25-000126.md) | [(0.03)](/filings/0001628280-25-049701.md) | not reported | [0.01](/filings/0001628280-26-032412.md) | [0.10](/filings/0001628280-26-054499.md) | [0.11](/filings/0001628280-25-049701.md) | not reported | [0.04](/filings/0001628280-26-032412.md) | [0.13](/filings/0001628280-26-054499.md) |
| Basic EPS | $ per share | [(0.03)](/filings/0001759509-24-000128.md) | not reported | [(0.08)](/filings/0001759509-25-000088.md) | [0.01](/filings/0001759509-25-000126.md) | [(0.03)](/filings/0001628280-25-049701.md) | not reported | [0.01](/filings/0001628280-26-032412.md) | [0.10](/filings/0001628280-26-054499.md) | [0.11](/filings/0001628280-25-049701.md) | not reported | [0.04](/filings/0001628280-26-032412.md) | [0.13](/filings/0001628280-26-054499.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfRevenue
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [591](/filings/0001759509-24-000128.md) | [559](/filings/0001628280-26-006960.md) | [508](/filings/0001759509-25-000088.md) | [604](/filings/0001759509-25-000126.md) | [770](/filings/0001628280-25-049701.md) | [759](/filings/0001628280-26-006960.md) | [985](/filings/0001628280-26-032412.md) | [914](/filings/0001628280-26-054499.md) | [1,306](/filings/0001628280-25-049701.md) | [1,132](/filings/0001628280-26-054499.md) | [1,035](/filings/0001628280-26-032412.md) | [1,138](/filings/0001628280-26-054499.md) |
| Current assets | $m | [2,500](/filings/0001759509-23-000115.md) | [2,577](/filings/0001759509-25-000025.md) | [2,549](/filings/0001759509-24-000069.md) | [2,680](/filings/0001759509-24-000102.md) | [2,867](/filings/0001759509-24-000128.md) | [2,951](/filings/0001628280-26-006960.md) | [3,124](/filings/0001759509-25-000088.md) | [2,758](/filings/0001759509-25-000126.md) | [2,995](/filings/0001628280-25-049701.md) | [2,920](/filings/0001628280-26-054499.md) | [2,723](/filings/0001628280-26-032412.md) | [2,859](/filings/0001628280-26-054499.md) |
| Total assets | $m | [4,478](/filings/0001759509-23-000115.md) | [4,564](/filings/0001759509-25-000025.md) | [4,762](/filings/0001759509-24-000069.md) | [4,997](/filings/0001759509-24-000102.md) | [5,263](/filings/0001759509-24-000128.md) | [5,435](/filings/0001628280-26-006960.md) | [5,668](/filings/0001759509-25-000088.md) | [5,369](/filings/0001759509-25-000126.md) | [5,943](/filings/0001628280-25-049701.md) | [9,030](/filings/0001628280-26-054499.md) | [8,890](/filings/0001628280-26-032412.md) | [9,107](/filings/0001628280-26-054499.md) |
| Current liabilities | $m | [2,949](/filings/0001759509-23-000115.md) | [2,962](/filings/0001759509-25-000025.md) | [3,119](/filings/0001759509-24-000069.md) | [3,641](/filings/0001759509-24-000102.md) | [3,849](/filings/0001759509-24-000128.md) | [3,881](/filings/0001628280-26-006960.md) | [4,073](/filings/0001759509-25-000088.md) | [3,917](/filings/0001759509-25-000126.md) | [4,136](/filings/0001628280-25-049701.md) | [4,526](/filings/0001628280-26-054499.md) | [4,666](/filings/0001628280-26-032412.md) | [4,880](/filings/0001628280-26-054499.md) |
| Total liabilities | $m | [4,010](/filings/0001759509-23-000115.md) | [4,023](/filings/0001759509-25-000025.md) | [4,271](/filings/0001759509-24-000069.md) | [4,419](/filings/0001759509-24-000102.md) | [4,607](/filings/0001759509-24-000128.md) | [4,668](/filings/0001628280-26-006960.md) | [4,830](/filings/0001759509-25-000088.md) | [4,637](/filings/0001759509-25-000126.md) | [5,370](/filings/0001628280-25-049701.md) | [5,757](/filings/0001628280-26-054499.md) | [5,864](/filings/0001628280-26-032412.md) | [6,084](/filings/0001628280-26-054499.md) |
| Long-term debt | $m | [834](/filings/0001759509-23-000115.md) | [839](/filings/0001759509-25-000025.md) | [942](/filings/0001759509-24-000069.md) | [578](/filings/0001759509-24-000102.md) | [574](/filings/0001759509-24-000128.md) | [566](/filings/0001628280-26-006960.md) | [550](/filings/0001759509-25-000088.md) | [527](/filings/0001759509-25-000126.md) | [1,010](/filings/0001628280-25-049701.md) | [1,002](/filings/0001628280-26-054499.md) | [987](/filings/0001628280-26-032412.md) | [991](/filings/0001628280-26-054499.md) |
| Current portion of debt | $m | [26.4](/filings/0001759509-23-000115.md) | [25.8](/filings/0001759509-25-000025.md) | [29.3](/filings/0001759509-24-000069.md) | [39.8](/filings/0001759509-24-000102.md) | [40.2](/filings/0001759509-24-000128.md) | [38.9](/filings/0001628280-26-006960.md) | [39.4](/filings/0001759509-25-000088.md) | [46.6](/filings/0001759509-25-000126.md) | [52.8](/filings/0001628280-25-049701.md) | [50.6](/filings/0001628280-26-054499.md) | [56.1](/filings/0001628280-26-032412.md) | [53.3](/filings/0001628280-26-054499.md) |
| Shareholders' equity | $m | [468](/filings/0001759509-24-000128.md) | [542](/filings/0001628280-26-006960.md) | [491](/filings/0001628280-25-049701.md) | [578](/filings/0001628280-25-049701.md) | [656](/filings/0001628280-25-049701.md) | [767](/filings/0001628280-26-054499.md) | [838](/filings/0001628280-26-054499.md) | [733](/filings/0001628280-26-054499.md) | [573](/filings/0001628280-25-049701.md) | [3,274](/filings/0001628280-26-054499.md) | [3,026](/filings/0001628280-26-054499.md) | [3,024](/filings/0001628280-26-054499.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [2.3 d](/filings/0001759509-24-000128.md) | [43.5 d](/filings/0001628280-26-006960.md) | [156](/filings/0001759509-25-000088.md) | [276 d](/filings/0001759509-25-000126.md) | [264 d](/filings/0001628280-25-049701.md) | [153 d](/filings/0001628280-26-006960.md) | [287](/filings/0001628280-26-032412.md) | [344 d](/filings/0001628280-26-054499.md) | [291 d](/filings/0001628280-25-049701.md) | [246 d](/filings/0001628280-26-006960.md) | [308](/filings/0001628280-26-032412.md) | [350 d](/filings/0001628280-26-054499.md) |
| Share repurchases | $m | [0.0 d](/filings/0001759509-24-000128.md) | [0.0 d](/filings/0001628280-26-006960.md) | [50.0](/filings/0001759509-25-000088.md) | [0.0 d](/filings/0001759509-25-000126.md) | [0.0 d](/filings/0001628280-25-049701.md) | [0.0 d](/filings/0001628280-26-006960.md) | [0.0](/filings/0001628280-26-032412.md) | [200 d](/filings/0001628280-26-054499.md) | [200 d](/filings/0001628280-25-049701.md) | [100.0 d](/filings/0001628280-26-006960.md) | [300](/filings/0001628280-26-032412.md) | [100 d](/filings/0001628280-26-054499.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [356](/filings/0001759509-23-000115.md) | [374](/filings/0001759509-24-000069.md) | [382](/filings/0001759509-24-000102.md) | [389](/filings/0001759509-24-000128.md) | [402](/filings/0001759509-25-000088.md) | [412](/filings/0001759509-25-000126.md) | [412](/filings/0001628280-25-049701.md) | [424](/filings/0001628280-26-032412.md) | [423](/filings/0001628280-26-054499.md) | [413](/filings/0001628280-25-049701.md) | [402](/filings/0001628280-26-032412.md) | [386](/filings/0001628280-26-054499.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 378,540,249 at 2026-07-31, from the cover of the [10-Q filed 2026-08-07](/filings/0001628280-26-054499.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:47 ET. No prices; not investment advice.